AGP Picks
View all

Healthy Living Europe
Provided by AGP

Healthy Living Europe: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Europe.

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

Press releases published on April 2, 2026

Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of March 31, 2026
Apr. 2, 2026

Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of March 31, 2026

Indeterminate GlobeNewswire
Information relative au nombre total des droits de vote et d’actions composant le capital social au 31 mars 2026
Apr. 2, 2026

Information relative au nombre total des droits de vote et d’actions composant le capital social au 31 mars 2026

Indeterminate GlobeNewswire
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Apr. 2, 2026

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Regeneron Collaborates with TriNetX to Access De-Identified Electronic Health Records of 300 Million Patients to Drive Research and Product Development in Life Sciences and Digital Health Solutions
Apr. 2, 2026

Regeneron Collaborates with TriNetX to Access De-Identified Electronic Health Records of 300 Million Patients to Drive Research and Product Development in Life Sciences and Digital Health Solutions

Indeterminate GlobeNewswire
Serina Therapeutics Announces NYSE American Acceptance of Continued Listing Compliance Plan
Apr. 2, 2026

Serina Therapeutics Announces NYSE American Acceptance of Continued Listing Compliance Plan

Indeterminate GlobeNewswire
New Material Innovations Drive Evolution in the Professional Wellness Tool Industry
Apr. 2, 2026

New Material Innovations Drive Evolution in the Professional Wellness Tool Industry

Indeterminate EIN Presswire
RxSight, Inc. to Participate in the 25th Annual Needham Virtual Healthcare Conference
Apr. 2, 2026

RxSight, Inc. to Participate in the 25th Annual Needham Virtual Healthcare Conference

Indeterminate GlobeNewswire
Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Apr. 2, 2026

Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
Apr. 2, 2026

Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)

Indeterminate GlobeNewswire
Relay Therapeutics to Present Initial Clinical Data on Zovegalisib in Vascular Anomalies at the International Society for the Study of Vascular Anomalies World Congress 2026
Apr. 2, 2026

Relay Therapeutics to Present Initial Clinical Data on Zovegalisib in Vascular Anomalies at the International Society for the Study of Vascular Anomalies World Congress 2026

Indeterminate GlobeNewswire
Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
Apr. 2, 2026

Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Apr. 2, 2026

Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Minerva Announces Leadership Transition
Apr. 2, 2026

Minerva Announces Leadership Transition

Indeterminate GlobeNewswire
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Apr. 2, 2026

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
FibroBiologics Announces Closing of $3 Million Public Offering
Apr. 2, 2026

FibroBiologics Announces Closing of $3 Million Public Offering

Indeterminate GlobeNewswire
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Apr. 2, 2026

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Summary Notice of Pendency and Proposed Settlement of Stockholder Derivative Actions
Apr. 2, 2026

Summary Notice of Pendency and Proposed Settlement of Stockholder Derivative Actions

Indeterminate GlobeNewswire
Enamine's IDD Platform Accelerates Nuclide Therapeutics' Precision Radiotheranostics Pipeline Towards the Clinic
Apr. 2, 2026

Enamine's IDD Platform Accelerates Nuclide Therapeutics' Precision Radiotheranostics Pipeline Towards the Clinic

Indeterminate EIN Presswire
Visory Health se posiciona entre las principales tarjetas de descuento para medicamentos bajo prescripción en Estados Unidos, ofreciendo a millones de personas acceso a tratamientos asequibles
Apr. 2, 2026

Visory Health se posiciona entre las principales tarjetas de descuento para medicamentos bajo prescripción en Estados Unidos, ofreciendo a millones de personas acceso a tratamientos asequibles

Indeterminate GlobeNewswire
Get Summer-Season Ready with New Notorious Fitness Training Plans
Apr. 2, 2026

Get Summer-Season Ready with New Notorious Fitness Training Plans

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Healthy Living Europe

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.